Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Withdrawn 1 Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1476 Neoplasms 999 Colorectal Neoplasms 830 Carcinoma, Non-Small-Cell Lung 724 Carcinoma, Hepatocellular 683 Stomach Neoplasms 647 Lung Neoplasms 584 Prostatic Neoplasms 543 Pancreatic Neoplasms 456 Rectal Neoplasms 338 Uterine Cervical Neoplasms 303 Colonic Neoplasms 295 Neoplasm Metastasis 292 Ovarian Neoplasms 285 Esophageal Neoplasms 279 Recurrence 278 Leukemia, Myeloid, Acute 253 Head and Neck Neoplasms 241 Multiple Myeloma 232 Brain Neoplasms 204 Polycystic Ovary Syndrome 200 Nasopharyngeal Carcinoma 198 Melanoma 198 Precursor Cell Lymphoblastic Leukemia-Lymphoma 195 Urinary Bladder Neoplasms 193 Lymphoma 178 Liver Neoplasms 178 Endometrial Neoplasms 159 Motor Activity 147 Lymphoma, Large B-Cell, Diffuse 141

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × OTHER × Nevus, Sebaceous of Jadassohn × Clear all

NCT03993821 2022-03-07

Burosumab for CSHS

Children's National Research Institute

Phase EARLY_PHASE1 Unknown

Nevus, Sebaceous of Jadassohn

Data powered by HemOnc (CC BY 4.0) Colophon ⚡